Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemischer Name: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N4-((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4R,5S,6R)-3-acetamido-5-(((2S,3S,4S,5R,6R)-4-(((2R,3S,4S,5S,6R)-3-(((2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydr oxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydro // Synonyme: Fmoc-Asn(1S(Bn),2G)-OH, Common glycan name: G2S1 [6] alpha(2, 6), Oxford glycan name: A2G2[6]S(6)1, Alternative Glycan names: A2G2S1, A2G2[6]S1, GlyCosmos ID: G75850OP
Ab 920,00 €
Fmoc-protected Asn-linked A2G2S1 glycan with benzyl ester-protected sialylic acid unit for use in solid phase peptide synthesis (SPPS).
Prompt Chemoenzymatic Synthesis of Diverse Complex-Type Oligosaccharides and Its Application to the Solid-Phase Synthesis of a Glycopeptide with Asn-Linked Sialyl-undeca- and Asialo-nonasaccharides; Y. Kjihara, Y. Suzuki, N. Yamamoto, K. Sasaki, T. Sakakibara, L. R. Juneja; Chem. Eur. J. 2004; 10: 971-985. https://doi.org/10.1002/chem.200305115
Chemical Synthesis of Homogeneous Human Glycosyl-interferon-â That Exhibits Potent Antitumor Activity in Vivo; I. Sakamoto, K. Tezuka, K. Fukae, K. Ishii, K. Taduru, M. Maeda, M. Ouchi, K. Yoshida, Y. Nambu, J. Igarashi, N. Hayashi, T. Tsuji, Y. Kajihara; J. Am. Chem. Soc. 2012; 134: 5428−5431. https://doi.org/10.1021/ja2109079
Bitte senden Sie mir mehr Informationen über